The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-Diamino-5-isopropyl-6-(3',4'-dichlorophenylsulfanyl)-7Hpyrrolo[2,3-d]pyrimidine ID: ALA477151
PubChem CID: 24950854
Max Phase: Preclinical
Molecular Formula: C15H15Cl2N5S
Molecular Weight: 368.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1c(Sc2ccc(Cl)c(Cl)c2)[nH]c2nc(N)nc(N)c12
Standard InChI: InChI=1S/C15H15Cl2N5S/c1-6(2)10-11-12(18)20-15(19)22-13(11)21-14(10)23-7-3-4-8(16)9(17)5-7/h3-6H,1-2H3,(H5,18,19,20,21,22)
Standard InChI Key: ZANQFNCQCCPBKV-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
13.6077 -12.4968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6065 -13.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3211 -13.7367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3193 -12.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0345 -12.4931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0348 -13.3240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8250 -13.5806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3133 -12.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8234 -12.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8918 -13.7358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3169 -11.2594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1346 -12.9042 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.5370 -13.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1117 -14.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5134 -15.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3390 -15.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7612 -14.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3571 -13.6327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1902 -11.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7330 -10.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0133 -11.4442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5860 -14.3579 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.7423 -15.7822 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4 11 1 0
8 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
9 19 1 0
9 5 1 0
19 20 1 0
4 1 1 0
19 21 1 0
2 10 1 0
17 22 1 0
5 6 1 0
16 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.29Molecular Weight (Monoisotopic): 367.0425AlogP: 4.70#Rotatable Bonds: 3Polar Surface Area: 93.61Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.13CX Basic pKa: 8.33CX LogP: 4.86CX LogD: 3.90Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.62Np Likeness Score: -0.85
References 1. Gangjee A, Jain HD, Queener SF, Kisliuk RL.. (2008) The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents., 51 (15): [PMID:18605720 ] [10.1021/jm800244v ]